MedPath

DEPARTMENT OF HEALTH

🇦🇺Australia
Ownership
-
Established
1989-01-01
Employees
-
Market Cap
-
Website
http://www.dh.gov.hk/

Clinical Trials

287

Active:3
Completed:275

Trial Phases

5 Phases

Phase 1:5
Phase 2:1
Phase 3:4
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (261 trials with phase data)• Click on a phase to view related trials

Not Applicable
247 (94.6%)
Phase 1
5 (1.9%)
Phase 3
4 (1.5%)
Phase 4
4 (1.5%)
Phase 2
1 (0.4%)

Textbook Outcomes After Oesophagectomy in Regional Australia

Not yet recruiting
Conditions
Oesophageal Cancer Nos
First Posted Date
2024-12-06
Last Posted Date
2024-12-06
Lead Sponsor
Launceston General Hospital
Target Recruit Count
100
Registration Number
NCT06721715
Locations
🇦🇺

Launceston General Hospital, Launceston, Tasmania, Australia

Post Oesophagectomy Outcomes in a Single Regional Centre in Australia

Not yet recruiting
Conditions
Oesophageal Cancer
First Posted Date
2024-10-29
Last Posted Date
2024-11-05
Lead Sponsor
Launceston General Hospital
Target Recruit Count
100
Registration Number
NCT06662513
Locations
🇦🇺

Launceston General Hospital, Launceston, Tasmania, Australia

A Randomised, Blinded Study on Laparoscopic Mesh Reinforcement for Chronic Groin Pain

Phase 3
Conditions
Chronic Groin Pain
First Posted Date
2009-07-08
Last Posted Date
2010-03-16
Lead Sponsor
Royal Hobart Hospital
Target Recruit Count
80
Registration Number
NCT00934388
Locations
🇦🇺

Royal Hobart Hospital, Hobart, Tasmania, Australia

U Clip Study - Study to Compare U Clip Anastomosis With Conventional Continuous Prolene Anastomosis

Phase 1
Conditions
Haemodialysis
First Posted Date
2009-01-26
Last Posted Date
2010-03-16
Lead Sponsor
Royal Hobart Hospital
Target Recruit Count
40
Registration Number
NCT00829153
Locations
🇦🇺

Launceston general Hospital, Launceston, Australia

A Randomised Study to Assess Betadine in the Groin Wound of Patients Undergoing Primary Varicose Vein Surgery

Phase 3
Terminated
Conditions
Varicose Veins
Wound Infection
Recurrence
Interventions
First Posted Date
2007-07-13
Last Posted Date
2017-04-12
Lead Sponsor
Royal Hobart Hospital
Target Recruit Count
60
Registration Number
NCT00500669
Locations
🇦🇺

Royal Hobart Hospital, Hobart, Tasmania, Australia

  • Prev
  • 1
  • 2
  • Next

News

Hong Kong Establishes Independent Drug Regulatory Authority by End 2026, Ending Reliance on Foreign Approvals

Hong Kong will launch its own drug and medical device regulator by late 2026, marking a significant shift from the current secondary evaluation system that requires approval from at least two overseas regulators.

Hong Kong Streamlines Drug Registration Process with New Consultation Services

Hong Kong's Department of Health is launching consultation services to help pharmaceutical companies navigate the "1+" drug registration mechanism, starting with an online seminar on March 31, 2025.

Philippine Senator Urges Fast-Track Approval of Takeda's TAK-003 Dengue Vaccine Amid 56% Case Surge

Philippines reports a dramatic 56% increase in dengue cases during the first six weeks of 2025, with over 43,000 cases recorded across key regions including Calabarzon, Metro Manila, and Central Luzon.

Philippine Clinical Trial for Virgin Coconut Oil as COVID-19 Treatment Expected to Conclude by December

A clinical trial in the Philippines is evaluating virgin coconut oil (VCO) as a potential treatment for COVID-19, with results anticipated by December.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.